BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Stanford University
Mayo Clinic
Children's Oncology Group
City of Hope Medical Center
Mayo Clinic
Emory University